1.    Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

 

2.1. Qualitative Research

2.1.1.     Primary & Secondary Sources

2.2. Quantitative Research

2.2.1.     Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.3.1.     Secondary Research

2.3.2.     Primary Research

2.4. Breakdown of Primary Research Respondents

2.5. Market Size Estimation

2.6. Assumption For The Study

2.7. Market Breakdown & Data Triangulation

3.    Executive Summary

 

4.    Global Healthcare Contract Research Organization Market Insights

 

4.1. Industry Value Chain Analysis

4.2. DROC Analysis

4.2.1.     Growth Drivers

4.2.2.     Restraints

4.2.3.     Opportunities

4.2.4.     Challenges

4.3. Technological Landscape

4.4. Regulatory Framework

4.5. Company Market Share Analysis,2020

4.6. Porter’s Five forces analysis

4.6.1.     Bargaining Power of Suppliers

4.6.2.     Bargaining Power of Buyers

4.6.3.     Threat of New Entrants

4.6.4.     Threat of Substitutes

4.6.5.     Intensity of Rivalry

4.7. Strategic Outlook

5.    Global Healthcare Contract Research Organization Market Overview

5.1. Market Estimates & Forecast By Value, 2021-2027

5.1.1.     By Value (USD)

5.2. Market Share & Forecast

 

       5.2.1. By Type

5.2.1.1. Discovery

5.2.1.2. CMC

5.2.1.3. Preclinical

5.2.1.4. Clinical Research

5.2.1.5. Laboratory Services

                     5.2.2. By Therapeutic Area

5.2.2.1. Oncology

5.2.2.2. CNS

5.2.2.3. Cardiovascular

                     5.2.3. By End Users

                             5.2.3.1. Pharmaceuticals

                             5.2.3.2. Medical Device

                     5.2.4. By Region

                             5.2.4.1. North America

                             5.2.4.2. Europe

                             5.2.4.3. Asia Pacific

                             5.2.4.4. South America

                             5.2.4.5. Middle East & Africa

 

6.    North America Healthcare Contract Research Organization Market

6.1. Market Estimates & Forecast By Value, 2021-2027

6.1.1.     By Value (USD)

6.2. Market Share & Forecast

6.2.1.     By Type

6.2.2.     By Therapeutic Area

6.2.3.     By End Users

6.2.4.     By Country

6.2.4.1.         U.S

6.2.4.2.         Canada

7.    Europe Healthcare Contract Research Organization Market

7.1. Market Estimates & Forecast By Value, 2021-2027

7.1.1.     By Value (USD)

7.2. Market Share & Forecast

7.2.1.     By Type

7.2.2.     By Therapeutic Area

7.2.3.     By End Users

7.2.4.     By Country

7.2.4.1.         Germany

7.2.4.2.         U.K

7.2.4.3.         France

7.2.4.4.         Italy

7.2.4.5.         Rest of Europe

8.    Asia Pacific Healthcare Contract Research Organization Market

8.1. Market Estimates & Forecast By Value, 2021-2027

8.1.1.      By Value (USD)

8.2. Market Share & Forecast

8.2.1.     By Type

8.2.2.     By Therapeutic Area

8.2.3.     By End Users

8.2.4.     By Country

8.2.4.1.         China

8.2.4.2.         India

8.2.4.3.         Japan

8.2.4.4.         South Korea

8.2.4.5.         Rest of APAC

9.    South America Healthcare Contract Research Organization Market

9.1. Market Estimates & Forecast By Value, 2021-2027

9.1.1.     By Value (USD)

9.2. Market Share & Forecast

9.2.1.     By Type

9.2.2.     By Therapeutic Area

9.2.3.     By End Users

9.2.4.     By Country

9.2.4.1.         Brazil

9.2.4.2.         Mexico

9.2.4.3.         Argentina

9.2.4.4.         Rest of Latin America

10. Middle East & Africa Healthcare Contract Research Organization Market

10.1.   Market Estimates & Forecast By Value, 2021-2027

10.1.1.   By Value (USD)

10.2.   Market Share & Forecast

10.2.1.   By Type

10.2.2.   By Therapeutic Area

10.2.3.   By End Users

10.2.4.   By Country

10.2.4.1.      Saudi Arabia

10.2.4.2.      UAE

10.2.4.3.      South Africa

10.2.4.4.      Rest of MEA

 

11. Company Profile (Company Overview, Financial Matrix, Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

·         IQVIA (US)

·         LabCorp (US)

·         Syneos Health (US)

·         PAREXEL (US)

·         PPD (US)

·         CON plc (Ireland)

·         PRA Health Sciences (US)

·         Charles River (US).

·         Other prominent players

12. Strategic Recommendation

*Financial Details Not Be Captured in Case of Unlisted Companies

 

**The segmentation and the companies are subjected to modifications based on the in-depth secondary for the final deliverable